234 related articles for article (PubMed ID: 29575033)
1. Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
Joers JM; Deelchand DK; Lyu T; Emir UE; Hutter D; Gomez CM; Bushara KO; Eberly LE; Öz G
Ann Neurol; 2018 Apr; 83(4):816-829. PubMed ID: 29575033
[TBL] [Abstract][Full Text] [Related]
2. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
4. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
[TBL] [Abstract][Full Text] [Related]
5. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
Adanyeguh IM; Henry PG; Nguyen TM; Rinaldi D; Jauffret C; Valabregue R; Emir UE; Deelchand DK; Brice A; Eberly LE; Öz G; Durr A; Mochel F
Mov Disord; 2015 Apr; 30(5):662-70. PubMed ID: 25773989
[TBL] [Abstract][Full Text] [Related]
6. Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy.
Lirng JF; Wang PS; Chen HC; Soong BW; Guo WY; Wu HM; Chang CY
PLoS One; 2012; 7(10):e47925. PubMed ID: 23118909
[TBL] [Abstract][Full Text] [Related]
7. Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3.
Chandrasekaran J; Petit E; Park YW; du Montcel ST; Joers JM; Deelchand DK; Považan M; Banan G; Valabregue R; Ehses P; Faber J; Coupé P; Onyike CU; Barker PB; Schmahmann JD; Ratai EM; Subramony SH; Mareci TH; Bushara KO; Paulson H; Durr A; Klockgether T; Ashizawa T; Lenglet C; Öz G;
Ann Neurol; 2023 Apr; 93(4):686-701. PubMed ID: 36511514
[TBL] [Abstract][Full Text] [Related]
8. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
9. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
10. Genotype-specific spinal cord damage in spinocerebellar ataxias: an ENIGMA-Ataxia study.
Rezende TJR; Adanyaguh I; Barsottini OGP; Bender B; Cendes F; Coutinho L; Deistung A; Dogan I; Durr A; Fernandez-Ruiz J; Göricke SL; Grisoli M; Hernandez-Castillo CR; Lenglet C; Mariotti C; Martinez ARM; Massuyama BK; Mochel F; Nanetti L; Nigri A; Ono SE; Öz G; Pedroso JL; Reetz K; Synofzik M; Teive H; Thomopoulos SI; Thompson PM; Timmann D; van de Warrenburg BPC; van Gaalen J; França MC; Harding IH
J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):682-690. PubMed ID: 38383154
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies.
Krahe J; Binkofski F; Schulz JB; Reetz K; Romanzetti S
Neurosci Biobehav Rev; 2020 Jan; 108():854-865. PubMed ID: 31838195
[TBL] [Abstract][Full Text] [Related]
12. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.
Oz G; Iltis I; Hutter D; Thomas W; Bushara KO; Gomez CM
Cerebellum; 2011 Jun; 10(2):208-17. PubMed ID: 20838948
[TBL] [Abstract][Full Text] [Related]
13. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
[TBL] [Abstract][Full Text] [Related]
14. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1.
Emir UE; Brent Clark H; Vollmers ML; Eberly LE; Öz G
J Neurochem; 2013 Dec; 127(5):660-8. PubMed ID: 24032423
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.
Oz G; Hutter D; Tkác I; Clark HB; Gross MD; Jiang H; Eberly LE; Bushara KO; Gomez CM
Mov Disord; 2010 Jul; 25(9):1253-61. PubMed ID: 20310029
[TBL] [Abstract][Full Text] [Related]
17. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia.
Coarelli G; Darios F; Petit E; Dorgham K; Adanyeguh I; Petit E; Brice A; Mochel F; Durr A
Neurobiol Dis; 2021 Jun; 153():105311. PubMed ID: 33636389
[TBL] [Abstract][Full Text] [Related]
18. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
[TBL] [Abstract][Full Text] [Related]
19. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
Jacobi H; Hauser TK; Giunti P; Globas C; Bauer P; Schmitz-Hübsch T; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; Tezenas du Montcel S; Borkert J; Schulz JB; Klockgether T
Cerebellum; 2012 Mar; 11(1):155-66. PubMed ID: 21701895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
